SLC6A1 and red-green color blindness: Conversely, none of the patients with mutations directly linked to GABAergic transmission (e.g., SLC6A1, GABRA3, GABRG3) responded to CBD, suggesting that genetic disruptions in GABAergic signaling might negatively impact CBD effectiveness.